2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Immunology and Cancer
Cancer remains a leading cause of mortality globally, and its yearly death toll of 8.2 million people is only anticipated to rise as the world's population ages. The presence of tumor-associated inflammatory cells in cancers poses a critical concern that is one of oncology's most pressing issues. Immunotherapy, which targets the immune system, has revolutionized cancer treatment in the previous decade. Many important questions about the causal relationship between chronic inflammation and carcinogenesis have been answered by immunological tests over the last two decades. Recent clinical and preclinical research has begun to reveal the wide range of systemic immune perturbations that occur during cancer development, and the critical role of peripheral immune cells in the anticancer immune response.
- Onco immunology
- Preclinical Models
- Inflammation
- Carcinogenesis
- Immune Checkpoint Inhibitors (Icis)
- Tumor Microenvironment (TME)
- Immune Therapies
- Peripheral Immune Cells and its Reorganization
Rajvir Dahiya
University of California San Francisco, United States
Michael Thompson
University of Toronto, Canada
Patricia Tai
UpToDate, United StatesSubmit your abstract Today
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Revolutionizing psychological care in oncology: A comprehensive review of emerging technologies and their impact on cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A systematic review of medical art therapy for cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : Effect of heterosteroids derived from sapogenin in PI3K/AKT/mTOR and apoptosis pathways in breast cancer cells
Nadia Leney Olazo Marquez, Benemérita Universidad Autónoma de Puebla, Mexico
Title : In search of common path in cancerous point mutations
Ratan Kumar Sarkar, Independent Researcher, India